ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 404 filers reported holding ENCOMPASS HEALTH CORP in Q1 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $846,149 | -2.4% | 12,599 | -1.6% | 0.01% | 0.0% |
| Q2 2023 | $866,553 | +21.6% | 12,798 | -2.8% | 0.01% | +20.0% |
| Q1 2023 | $712,497 | -9.1% | 13,170 | +0.5% | 0.01% | -23.1% |
| Q4 2022 | $783,750 | +47.6% | 13,104 | +11.7% | 0.01% | +30.0% |
| Q3 2022 | $531,000 | -20.2% | 11,729 | -1.2% | 0.01% | -23.1% |
| Q2 2022 | $665,000 | -43.4% | 11,867 | -28.1% | 0.01% | -35.0% |
| Q1 2022 | $1,174,000 | +7.7% | 16,504 | -1.2% | 0.02% | +17.6% |
| Q4 2021 | $1,090,000 | -14.0% | 16,709 | -1.1% | 0.02% | -29.2% |
| Q3 2021 | $1,268,000 | -5.6% | 16,897 | -1.8% | 0.02% | -4.0% |
| Q2 2021 | $1,343,000 | +8.3% | 17,213 | +13.7% | 0.02% | -3.8% |
| Q1 2021 | $1,240,000 | -0.4% | 15,135 | +0.5% | 0.03% | -3.7% |
| Q4 2020 | $1,245,000 | +27.4% | 15,057 | +0.2% | 0.03% | +12.5% |
| Q3 2020 | $977,000 | +17.4% | 15,032 | +11.8% | 0.02% | +14.3% |
| Q2 2020 | $832,000 | – | 13,441 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Copeland Capital Management, LLC | 569,048 | $28,117,000 | 1.78% |
| Kalos Management, Inc. | 76,118 | $3,761,000 | 1.77% |
| Bridge City Capital, LLC | 30,231 | $1,494,000 | 1.08% |
| DALTON GREINER HARTMAN MAHER & CO | 331,823 | $16,395,000 | 0.86% |
| Horrell Capital Management, Inc. | 28,641 | $1,415,000 | 0.74% |
| Polianta Ltd | 26,600 | $1,314,000 | 0.43% |
| GLOBEFLEX CAPITAL L P | 30,177 | $1,491,000 | 0.42% |
| CARILLON TOWER ADVISERS, INC. | 768,748 | $37,984,000 | 0.40% |
| EAGLE ASSET MANAGEMENT INC | 1,070,271 | $53,001,000 | 0.29% |
| S. R. Schill & Associates | 8,108 | $401,000 | 0.25% |